Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Merck
MRK
|
+$362M |
| 2 |
Prologis
PLD
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$305M |
| 4 |
Corteva
CTVA
|
+$235M |
| 5 |
Atlassian
TEAM
|
+$226M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.8B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$261M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$259M |
| 5 |
Danaher
DHR
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Remitly
RELY
$3.74B
| $7.75M | ﹤0.01% |
677,151
+60,866
| +10% | +$697K |
|
|
ESGR
1627
DELISTED
Enstar Group
ESGR
| $7.75M | ﹤0.01% |
33,544
-5,578
| -14% | -$1.29M |
|
1628
Clarivate
CLVT
$2.88B
| $7.75M | ﹤0.01% |
929,033
-128,489
| -12% | -$1.07M |
|
1629
Alignment Healthcare
ALHC
$3.18B
| $7.73M | ﹤0.01% |
656,910
-17,167
| -3% | -$202K |
|
1630
iRobot
IRBT
$107M
| $7.72M | ﹤0.01% |
160,497
-1,096
| -0.7% | -$52.7K |
|
1631
Wayfair
W
$11.4B
| $7.71M | ﹤0.01% |
234,444
+26,383
| +13% | +$868K |
|
1632
Papa John's
PZZA
$1.65B
| $7.7M | ﹤0.01% |
93,583
-7,698
| -8% | -$634K |
|
1633
Zillow
ZG
$20.4B
| $7.68M | ﹤0.01% |
246,021
+89,187
| +57% | +$2.78M |
|
1634
Orion
OEC
$521M
| $7.68M | ﹤0.01% |
430,978
+59,564
| +16% | +$1.06M |
|
1635
AdaptHealth
AHCO
$1.26B
| $7.67M | ﹤0.01% |
398,926
-238,631
| -37% | -$4.59M |
|
1636
JELD-WEN Holding
JELD
$537M
| $7.66M | ﹤0.01% |
794,006
+512,275
| +182% | +$4.94M |
|
1637
LCI Industries
LCII
$2.43B
| $7.65M | ﹤0.01% |
82,783
-16,837
| -17% | -$1.56M |
|
1638
Walker & Dunlop
WD
$2.93B
| $7.65M | ﹤0.01% |
97,516
-5,916
| -6% | -$464K |
|
1639
IDEAYA Biosciences
IDYA
$2.16B
| $7.61M | ﹤0.01% |
418,989
+152,173
| +57% | +$2.76M |
|
1640
Nurix Therapeutics
NRIX
$691M
| $7.58M | ﹤0.01% |
690,365
+137,709
| +25% | +$1.51M |
|
1641
PennyMac Financial
PFSI
$6.44B
| $7.57M | ﹤0.01% |
133,636
-14,526
| -10% | -$823K |
|
1642
Pebblebrook Hotel Trust
PEB
$1.38B
| $7.56M | ﹤0.01% |
564,729
-532,074
| -49% | -$7.12M |
|
|
BBBY
1643
Bed Bath & Beyond, Inc.
BBBY
$596M
| $7.56M | ﹤0.01% |
390,472
+239,861
| +159% | +$4.64M |
|
1644
Kohl's
KSS
$1.71B
| $7.55M | ﹤0.01% |
298,999
-80,511
| -21% | -$2.03M |
|
1645
Park National Corp
PRK
$2.72B
| $7.54M | ﹤0.01% |
53,565
+2,095
| +4% | +$295K |
|
1646
Methode Electronics
MEI
$287M
| $7.51M | ﹤0.01% |
169,226
-17,472
| -9% | -$775K |
|
|
BLUE
1647
DELISTED
bluebird bio
BLUE
| $7.5M | ﹤0.01% |
54,218
-1,784
| -3% | -$247K |
|
|
ZUO
1648
DELISTED
Zuora, Inc.
ZUO
| $7.46M | ﹤0.01% |
1,173,107
-228,902
| -16% | -$1.46M |
|
1649
PTC Therapeutics
PTCT
$4.85B
| $7.45M | ﹤0.01% |
195,161
-16,209
| -8% | -$619K |
|
1650
IPG Photonics
IPGP
$3.38B
| $7.38M | ﹤0.01% |
77,956
-477
| -0.6% | -$45.2K |
|